The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

On 15 January, the two agencies released respective lists of medicines approved last year ... had the highest number of new drugs, matching trends seen in previous years. The FDA meanwhile ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine ... oxycodone and fentanyl each year for pain. Nearly 108,000 people died from drug overdoses in 2022, with approximately ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of ... Americans fill prescriptions to treat each year, according to Vertex.

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

For the first time in over two decades, the U.S. Food and Drug Administration has approved a new kind of ... in Georgia is estimated at $21 million per year. This new drug could be a major ...

The FDA’s Center ... Research (CBER) approved 57 new therapeutic drugs (NTDs; see Fig. 1 for the definition) in 2024. This is slightly above the average of 53 NTDs per year for 2014–2024 ...

On Dec. 6, 2024, the FDA released draft guidance ... negotiation factor for drugs that are marketed under this approval pathway. CMS has already said in its Year 2027 Medicare Drug Price ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.